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ganic compounds with similar structures into groups of contaminant biodegradation with pure cultures of mi-
that make the commonality in basic microbial ap- croorganisms seems tractable with careful design of
proaches to degradation readily apparent. The value of media for isolation of the microbes of interest.
this book is greatly augmented by the availability of the As excellent as the book is, it could benefit from a
University of Minnesota Biocatalysis/Biodegradation chapter that deals with the environmental constraints on
data base (http://umbbd.ahc.umn.edu), which summa- biodegradation. Although the biodegradation abilities of
rizes a large number of the organic compounds known microorganisms are impressive, biodegradation has not
to be susceptible to microbial attack, the pathways for proven to be a panacea for organic contamination of
degradation, and some of the microorganisms known the environment. In many instances, the rate of microbial
to be capable of carrying out the relevant reactions. decontamination is too slow to prevent the spread of
As good a job as this book does in clearly and con- contaminants in groundwater or to restore surface envi-
cisely summarizing the vast amount of existing informa- ronments to a state suitable for most human needs.
tion on biodegradation, one of its main strengths is con- Reasons for this include (1) the organisms with the ap-
sistently emphasizing what is not known and suggesting propriate biodegradative abilities are not present; (2) the
areas of investigation ripe for future research. Wackett organisms are present but the availability of nutrients
and Hershberger emphasize that there are probably 10 or the appropriate electron donors or acceptors limit
million organic compounds on Earth whose biodegrada- activity; or (3) the contaminants are sequestered within
tion has not been studied and that the rate of introduc- the environmental matrix in such a way that the microor-
tion of new organic compounds by industry is much ganisms cannot access the contaminants. The physiologi-
faster than the biodegradation of these compounds can cal stresses on microorganisms living in soils, ground-
be investigated. Therefore, there is a need for the devel- water, or aquatic sediments is much different than when
opment of strategies that can predict the likely pathway these same organisms are living under more optimal
for the biodegradation of uninvestigated compounds conditions in culture flasks, and this can greatly impact
without conducting elaborate biodegradation studies. their biodegradative activity.
As emphasized in this book, some general rules for bio- One of the prime applications of information on bio-
degradation pathways are beginning to emerge, but the degradation is in the design of bioremediation strategies
ability to reliably predict the pathway for the degradation for contaminated environments. Unfortunately, only one
of new organic compounds is far from a reality. example of this is provided in the book, and this example
The increasing availability of microbial genomic data focuses on the use of a genetically engineered microor-
is expanding the understanding of microbial metabo- ganism. The vast majority of bioremediation is accom-
lism, but Wackett and Hershberger hold little hope that plished via the activity of indigenous microorganisms.
the study of microbial genomes alone will greatly ad- This book provides a very tight, coherent presentation
vance the field of biodegradation. The function of genes of a complex topic, providing a good overview of the
for novel biodegradation reactions cannot readily be important concepts without getting bogged down in the
predicted with current bioinformatics tools, even under details of all the potential biodegradation reactions,
the best of circumstances. For example, it may be possi- most of which can be found on the web site. Although
ble to determine via genomic analysis that an organism the book was written for graduate students and prac-
contains the gene for a cytochrome P450 monooxygen- titioners, it is likely to be an enjoyable read for anyone
ase, but determining what contaminants the cytochrome interested in the metabolic potential of microorganisms
interacts with is not possible without directly measuring or environmental sciences.
the activity of the protein. There is even less possibility of
predicting the function of a gene in a previously unknown
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biodegradation reaction from just the gene sequence. For
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example, the fact that important contaminants such as
University of Massachusettsbenzene and polycyclic aromatic hydrocarbons can be
Amherst, Massachusetts 01003degraded anaerobically, as has recently been discov-
ered, could not have been predicted from genomic anal-
ysis, even if the complete genome sequences of all Nearly Twenty Years
microorganisms were available. This is because the en-
after Barry Marshall’s Big Gulpzymes capable of initiating an anaerobic attack on un-
substituted aromatic hydrocarbons are not known.
These considerations emphasize the need for further
Helicobacter pylori: Physiology and Geneticsstudy on the physiology and biochemistry of biodegra-
Edited by Harry L.T. Mobley, George L. Mendz,dation reactions in cultured microorganisms. It is often
and Stuart L. Hazellinferred that many of the environmentally relevant micro-
Washington, DC: ASM Press (2001). 608 pp. $125.95organisms cannot be cultured because only a small per-
centage of the microorganisms living on Earth have been
recovered in pure culture. However, molecular studies
You’ve probably heard this story. It is not apocryphal.of contaminated aquifers have suggested that the mi-
The whole episode evokes the zeitgeist of an earlier eracroorganisms that are responsible for the degradation
of investigator-initiated, hypothesis-driven experimen-of contaminants such as aromatic hydrocarbons and
tation where the subjects were the scientists them-chlorinated solvents are similar to microorganisms in
selves. Almost 20 years ago, stomach biopsies frompure culture which carry out similar degradative reac-
tions. Thus, the study of environmentally relevant forms patients were being cultured in an attempt to retrieve a
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spiral-shaped microbe that had been associated with fluence of microbial, host, and environmental factors.
The challenge has been to identify these factors.gastritis and ulcers. The hospital microbiology lab was
dealing with an outbreak of antibiotic-resistant Staphy- Drs. Mobley, Mendz, and Hazell have assembled a
comprehensive, highly informative textbook that will belococcus aureus, putting these “experimental” biopsy
cultures low on the queue of things that needed to be invaluable for those who are just entering the field, as
well as for the cognoscenti. Assembling 46 chaptersexamined. A set of plates was left in the incubator over
a long holiday weekend and not inspected until six days written by 95 authors into a cohesive whole is a daunting
task for even the most intrepid editors. In this case, theyhad elapsed, instead of the customary two-day interval.
The six-day time frame was just right for Helicobacter have done an admirable job of organizing a vast amount
of information into seven sections. The reader is ablepylori, the slow-growing, gram-negative, microaero-
philic bacterium, to make its presence first known. Two to easily move from a concise, well-balanced discussion
of the epidemiology of infection at the beginning of theyears later, in the tradition of self-experimenters like
Daniel Carrio´n, Max von Pettenkofer, David A. Robinson, volume, to helpful reconstructions of bacterial physiology
and metabolic regulation (aided by knowledge gleanedand Walter Reed’s brave colleagues Jesse Lazear, Aris-
tides Agramonte, and James Carroll (L.K. Altman, Who from its, and other microbial genome sequences), to
detailed discussions of H. pylori genetics, to overviewsGoes First: The Story of Self-Experimentation in Medi-
cine, University of California Press, 1998), a young inves- of the determinants of virulence and descriptions of
elicited host responses (from inflammation to cancer),tigator swallowed 109 colony forming units of this mi-
crobe. Barry Marshall’s “big gulp” produced gastritis, and finally to summaries of how host-microbial relation-
ships are being modeled and dissected in animals. Thewhich is the precursor to peptic ulcer disease. His symp-
toms subsided with antibiotic treatment, Koch’s postu- chapters are well referenced and remarkably up to date.
From its first entry (ABC transporters) to its last (zoono-lates for gastritis were fulfilled, the treatment for peptic
ulcers was revolutionized, and we were provided with sis), the index serves as a user-friendly guide for retriev-
ing specific bits of information from the bundle of factsa vivid demonstration that a chronic disease had a here-
tofore unappreciated infectious basis. The story inspired presented in this exceptional reference source.
A certain degree of redundancy is inevitable in compi-others to search for cryptic microbes that may cause
diseases such as multiple sclerosis, atherosclerosis, lations such as this. Nonetheless, all the central “themes
and melodies” of this bug and its infection are well repre-and rheumatoid arthritis.
Fast forward 20 years, past a mountain of 10,624 pub- sented. For example, there is an excellent review of what
is known and not known about transmission. Acquisitionlished papers with Helicobacter pylori (or its earlier nom
de plumes Campylobacter pyloridis and C. pylori) in their typically occurs in childhood, with studies emphasizing
intrafamilial spread, yet the exact mode of transmissiontitles, past complete annotated genome sequences from
two different H. pylori strains, and we come to the pres- remains controversial. Features of H. pylori that help
support a sustained host-bacterial relationship are ex-ent. We find ourselves with a great deal of knowledge,
but still needing enlightenment about how this bacte- plored in depth throughout the text—from the outer
membrane LPS and its lipid A component that help re-rium has learned to insinuate itself in the stomachs of
approximately one half of our fellow humans. duce immunologic responses, to the organism’s amaz-
ingly plastic genome.To paraphrase a prominent American politician, H.
pylori is a “uniter not a divider.” It has attracted a diverse, The enormous value of knowing the complete genome
sequence of two H. pylori strains is emphasized in nu-multidisciplinary consortium of microbiologists, cell bi-
ologists, cancer biologists, epidemiologists, and others merous chapters. H. pylori has a relatively small ge-
nome, like many highly host-adapted bacterial species.who are seeking to understand how this organism is
able to adapt to, and persist within, its specialized gas- There is a paucity of encoded global regulatory proteins
and “two component regulatory systems” that so manytric niche for decades at a time. They have asked why
the host-bacterial relationship in most cases is relatively other bacterial species use for modulating adaptations
to changing physiologic conditions. Instead, this organ-innocent while in others, the destiny of infection is
skewed toward development of severe pathology. Mar- ism appears to lean heavily on its capacity for genetic
variation to achieve and maintain fitness in host nichestin Blaser, a prominent worker and conceptualizer in
this field, suggests we consider H. pylori as having an that evolve over the course (and as a consequence) of
prolonged infection.“amphibiotic relationship” with its hosts, where patho-
genic significance is determined by context (In Helico- Genetic diversity among H. pylori populations is mani-
fested by variations in gene order, gene content, andbacter pylori: basic mechanisms to clinical cure 1998,
pp. 43–48, R.H. Hunt and G.N.J. Tytgat, eds., Dordrecht, gene sequence. Recombination appears to be a more
prominent driver of diversification than in other bacterialThe Netherlands: Kluwer Academic Publishers, 1998).
On the one hand, we know that the presence of the species (formally stated, this organism has a “recombi-
national or panmictic population structure”). H. pyloriorganism is associated with increased risk for peptic
ulcer disease and gastric adenocarcinoma. On the other strains, in turn, contain a multitude of genes with homol-
ogy to components of restriction-modification (R-M)hand, the absence of H. pylori appears to be associated
with a greater risk of developing gastroesophageal re- systems. The full significance of these diverse strain-
specific ensembles of complete and seemingly incom-flux disease (GERD for acronym lovers), as well as its
ominous potential consequences (esophageal cancer). plete R-M systems remains to be deciphered. They may
serve many functions: as a type of “immune system” thatColonization may also protect from pathogens that
cause diarrheal illnesses in childhood. The general view protects the genome from invasion by large fragments of
“foreign” DNA while still allowing for incorporation ofis that disease risk stems from a hard-to-pin-down con-
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smaller pieces of DNA via recombination, or as modula- opportunistic infections and malignancies in male ho-
mosexuals heralded the onset of the AIDS epidemic. Thetors of gene expression through methylation of cis-act-
ing transcriptional regulatory elements. Like some other subsequent identification of human immunodeficiency
virus as the etiologic agent of AIDS led quickly to ainfamous mucosal pathogens (H. influenzae and Neisse-
ria spp), H. pylori uses slipped-strand mispairing to spur search for agents capable of inhibiting viral replication
and restoring immune function. Since the first reportits adaptive evolution within its host niche: the resulting
frame-shift mutations act as switches to turn production of successful pharmacologic impact on HIV-1 disease
progression in 1987, fifteen drugs belonging to threeof proteins on or off. There is extensive discussion of
how variation in gene content in the organism’s cag separate classes (nucleoside reverse transcriptase inhibi-
tors [NRTI’s], non-nucleoside RT inhibitors [NNRTI’s],pathogenicity island (and the PAI’s type IV secretion
system) are intimately linked to host responses. and protease inhibitors [PI’s]) have been approved for
treatment of HIV-1 infection by the US Food and DrugThe editors note in their preface that they wanted
to create a book that “would summarize and review Administration, and over a dozen more are currently in
development. The use of these agents has dramaticallythe accumulated knowledge on this important human
pathogen.” They have succeeded. In 2004, exactly changed the clinical course of HIV-1 infection for those
fortunate enough to have access (Palella et al., N. Engl.twenty years will have elapsed since the “big gulp.” The
chances of making major advances in our understanding J. Med. 338, 853–860, 1998). At the same time, this
rapidly evolving field and the need to keep abreast ofthe biology of this microorganism and the determinants
of its host relationships could not be brighter. DNA mi- new developments represents a growing challenge to
croarrays containing more than 98% of the known ORFs clinicians and researcher alike.
of the two sequenced strains are now available for whole Antiretroviral Therapy summarizes much of the prog-
genome genotyping of clinical isolates (Salama et al., ress that has been made in the development of antiret-
Proc. Natl. Acad. Sci. USA 97, 14668–14673, 2000). Un- roviral therapeutic agents. Edited by Erik De Clercq, who
dertaking a comprehensive screen for the presence or also coauthored several of the chapters, this book offers
absence of bacterial genes in strains taken from defined a broad overview of each of the different classes of
patient populations, or from individuals over the course drugs currently available for inhibition of HIV and reviews
of their infection, provides an opportunity to build a progress toward the development of novel classes of
knowledge base for correlating microbial and host phe- anti-HIV-1 therapeutics. The major focus of the book is
notypes with H. pylori genotypes. Genetically manipulat- on the inhibitors themselves, rather than on their clinical
able and environmentally defined animal models are be- use, so much so that a more accurate title might have
coming available to model host traits thought to function been Antiretroviral Agents. Those seeking a discussion
as risk factors for development of severe pathology. of the vexing questions of when to initiate therapy, when
Methods are emerging for monitoring bacterial gene to change from one regimen to another, how to manage
expression in vivo (Rokbi et al., Infect. Immunol. 69, treatment-related toxicities, or under what circum-
4759–4766, 2001), raising the hope that both host and stances treatment interruption might be warranted will
microbial gene expression can be monitored simultane- find little discussion of those treatment-related topics
ously during the course of infection. The feasibility of in this edition. Readers will, however, find a thorough
conducting screens for essential H. pylori genes has discussion of the agents themselves, written in highly
been demonstrated (Chalker et al., J. Bacteriol. 183, readable style and containing helpful figures and tables.
1259–1268, 2001). The first reported large-scale pro- Unfortunately, given the rapid pace of antiretroviral drug
karyotic protein-protein interaction map has been pro- development, much of the material is already seriously
duced using information from the sequenced H. pylori out of date. Despite a publication date of 2001, most of
genome and a version of the yeast two-hybrid system the references date from 1999 or before, which in the
(Rain et al., Nature 409, 211–215, 2001). Amidst all of end is the most serious shortcoming of the book.
this emerging technology, this book should serve as an The chapters on reverse transcriptase inhibitors and
invaluable guide for placing new results into the broad- protease inhibitors provide thorough summaries of
est possible context. these agents. Particularly helpful is the thorough discus-
sion of pathways for phosphorylation and metabolism
Andrew J. Syder and Jeffrey I. Gordon of the nucleoside and nucleotide analogs, which must
Department of Molecular Biology and Pharmacology be activated intracellularly to their triphosphate or di-
Washington University School of Medicine phosphate forms, respectively. Detailed discussions of
Saint Louis, Missouri 63110 the calculated approach to the development of new
agents such as ABT-378 through structure/function
analyses provide interesting insights into drug discovery
Targeting HIV: Beyond Protease from authors who were involved in these processes,
but results of promising clinical studies that formed theand Reverse Transcriptase Inhibitors
basis for FDA approval are not discussed. Structural
considerations are also prominent in the chapter on the
non-nucleoside RT inhibitors (NNRTIs), which is illus-Antiretroviral Therapy
trated by helpful figures showing the structural basis forEdited by E.D.A. De Clercq
interaction of these inhibitors with RT; the chapter onWashington, DC: ASM Press (2001). 359 pp. $99.95
the protease inhibitors would have been strengthened
by inclusion of similar figures. Chapters on the RT inhibi-
tors and protease inhibitors would have been enhancedTwo decades ago, a report by the Centers for Disease
Control and Prevention (CDC) of an unusual cluster of by a discussion of the toxicities of these agents, but
